GALERA THERAPEUTICS INC (GRTX)

US36338D1081 - Common Stock

0.1861  -0.02 (-10.31%)

After market: 0.1879 +0 (+0.97%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
46.95M51.23M73.37M70.55M50.69M
Research and Development
24.11M31.01M52.42M54.85M42.33M
Selling, General, and Administrative Expenses
22.84M20.21M20.95M15.71M8.36M
Operating Income
-46.95M-51.23M-73.37M-70.55M-50.69M
Interest Income/Expense
-9.82M-11.07M-7.17M-3.68M-1.25M
Non Recurring Items
-2.31MN/AN/AN/AN/A
Income Before Taxes
-59.08M-62.29M-80.53M-74.23M-51.94M
Income Tax
0.00-70.00K0.00-20.00K-10.00K
Net Income
-59.08M-62.22M-80.53M-74.22M-59.11M
EBITDA
-46.69M-51.12M-72.59M-70.18M-50.42M
 
Per Share Data
EPS Diluted Total Ops
-1.33-2.30-3.12-2.98-2.38
Non GAAP EPS
N/A-2.30-3.13-2.98N/A
 
Statistics

All data in USD

Charts